Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Physical and social environment and the risk of multiple sclerosis.
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways?
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Meta-Analysis of the Correlation Between Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis.
Il-17 And Glutamte Excitotoxicity In The Pathogenesis Of Multiple Sclerosis.
Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
Abnormal nerve conduction study findings indicating the existence of peripheral neuropathy in multiple sclerosis and neuromyelitis optica.
[Clinical features and prognosis of pediatric multiple sclerosis].
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Association Between Urinary Symptoms and Urinary Tract Infection in Patients With Multiple Sclerosis.
Inter- and intra-laboratory comparison of JC polyomavirus antibody testing using two different virus-like particle (VLP)-based assays.
Interferon Beta and vitamin d synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Seasonal vitamin D changes and the impact on health risk assessment.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Depressive Symptoms in Multiple Sclerosis from an In Vivo Study with TBSS.
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
Treatment of optic neuritis with erythropoietin (TONE): a randomised, double-blind, placebo-controlled trial-study protocol.
Pages
« first
‹ previous
…
383
384
385
386
387
388
389
390
391
…
next ›
last »